Michael Pezold, MD
Vascular Surgery · Santa Rosa, CANPI 1720377856
Payments from drug & device makers
Across 115 payments — averaging $132.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$9K
- Penumbra, Inc.$2K
- Medtronic$1K
- Endologix LLC$954
- Silk Road Medical, Inc.$575
- Boston Scientific$532
- plus $822 from 14 others
What the payments were for
- Consulting fees$5,95039%
- Speaking & faculty fees$4253%
- Travel & lodging$3,48123%
- Food & beverage$5,18634%
- Education$1581%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 34 | $9,347 |
| Penumbra, Inc. | 3 | $1,586 |
| Medtronic(2 entities) | 17 | $1,385 |
| Endologix LLC | 7 | $954 |
| Silk Road Medical, Inc. | 12 | $575 |
| Boston Scientific | 14 | $532 |
| Inari Medical, Inc. | 2 | $151 |
| Cook Medical LLC | 6 | $133 |
| Mimedx Group, Inc. | 3 | $87 |
| Globus Medical | 1 | $80 |
| Terumo Medical Corporation | 3 | $73 |
| Heron Therapeutics, Inc. | 3 | $56 |
| Philips North America LLC | 1 | $53 |
| Smith+Nephew | 2 | $41 |
| Tactile Systems Technology Inc | 2 | $34 |
| Johnson & Johnson | 1 | $29 |
| Sanara Medtech Inc. | 1 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Biotissue Holdings Inc. | 1 | $17 |
| Lemaitre Vascular, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIENCE SIERRA$3,825
- Omnilink Elite vascular stent system$3,142
- Indigo System$1,586
- PERCLOSE PROGLIDE$921
- Torus Stent Graft System$839
- ENDOCROSS Device$839
- ENROUTE Transcarotid Neuroprotection System$689
- Valiant Captivia$444
- ABSOLUTE PRO$405
- ENDURANT IIS$299
- Endurant$231
- ENROUTE Transcarotid Stent$211
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$211
- OMNILINK ELITE$169
- ENROUTE Transcarotid Stent System$162
- ENHANCE Transcarotid Peripheral Access Kit$162
- ENROUTE 0.014 Guidewire$162
- JETI$129
- FLOWTRIEVER CATHETER, S$125
- CT THROMBECTOMY SYSTEM KIT$125
How this compares
$15,200 in reported general payments places this provider in the 75th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $23,425 |
| ClopidogrelClopidogrel Bisulfate | 102 | $1,412 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 56 | $360 |
| Gabapentin | 21 | $299 |
| Cilostazol | 13 | $190 |
| Atorvastatin Calcium | 16 | $61 |
| Rosuvastatin Calcium | 14 | $52 |
| Diazepam | 11 | $4 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Santa Rosa
- Venita ChandraPalo Alto$947K
- Leigh Ann ObanionFresno$932K
- Sukgu HanLos Angeles$765K
- Mahmoud Malasla Jolla$508K
- Son DuongFountain Valley$503K
- Leo FongClovis$496K
- Jason LeePalo Alto$403K
- Bernardo Curi MendesLos Angeles$376K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.